📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Amyloid-ß peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome. (2024)

First Author: Kasri A

Attributed to: Reducing the production of toxic Abeta peptides in Alzheimer's disease by mutating the APP cholesterol-binding site: a new therapeutic strategy? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00401-024-02756-4

PubMed Identifier: 39026031

Publication URI: http://europepmc.org/abstract/MED/39026031

Type: Journal Article/Review

Volume: 148

Parent Publication: Acta neuropathologica

Issue: 1

ISSN: 0001-6322